Cheng et al. found the combination of prostate-specific antigen (PSA) value and the percentage of cancer in the biopsy specimen to predict the risk for positive margins and proposed a model based on these two variables to select the candidates for NS [33]. The gene discussed is KLK3; the disease is cancer.